Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2022-11-22 2022-09-30
Drug Identification Number 00037869 00037869
Brand name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Common or Proper name POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE USP
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients POTASSIUM CHLORIDE POTASSIUM CHLORIDE
Strength(s) 149MG 149MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 25 x 10mL vial 25 x 10mL vial
ATC code B05XA B05XA
ATC description I.V. SOLUTION ADDITIVES I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-10-01 2022-10-01
Estimated end date 2023-01-30
Actual end date 2022-11-21
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Inventory is on preventative allocation.
Health Canada comments